Information from Industry - Sponsored CME Supplement

Non-Surgical Treatment of Heavy Menstrual Bleeding From Fibroids: A New Paradigm

This program is supported by an unrestricted educational grant provided by Myovant, Inc. This content was prepared by the specialized content division of FMC and peer reviewed by OBG Management.


GnRH antagonists with estrogen/progesterone are promising new uterine-sparing options for treating uterine fibroids. Two experts review data from two recent clinical trials to bring you up to speed on the benefits and risks of this treatment approach.

After reading this short article, you have an opportunity to earn 1.0 CME credits.

Click here to read more

Recommended Reading

Myths about smoking, diet, alcohol, and cancer persist
MDedge ObGyn
New AHA statement urges focus on CV risk before pregnancy
MDedge ObGyn
Endometriosis: Whole-Body Effects, Treatments and Infertility
MDedge ObGyn
Prepare for endometriosis excision surgery with a multidisciplinary approach
MDedge ObGyn
Can California solve its ob.gyn. shortage?
MDedge ObGyn